Self-propelled gas nanomotor-integrated microneedles for melanoma therapy: Dual-action in situ eradication and metastatic suppression
Source abstract
Abstract
Skin cancer, particularly malignant melanoma, is one of the most prevalent cancers globally, affecting millions annually. Traditional treatments like excision, chemotherapy, and immunotherapy often fail due to their invasiveness, toxicity, and poor drug delivery efficiency caused by skin barriers. Microneedles (MNs) offer a minimally invasive alternative, directly penetrating the skin to deliver drugs to tumor sites while minimizing side effects. However, their penetration depth is limited, and they do not address metastatic lesions. This study developed a gas motor-driven multi-responsive microneedle patch that significantly enhances subcutaneous drug penetration through a gas propulsion mechanism, greatly expanding the drug's diffusion range. Combined with photothermal therapy (PTT) and chemotherapy, this approach rapidly kills melanoma cells locally, induces immunogenic cell death (ICD), and uses anti-PD-1 antibodies (aPD-1) targeting immune checkpoints to enhance efficacy, overcome tumor immune escape, and activate systemic immune responses, achieving remote tumor suppression through local treatment only.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Orbital Angular Momentum in Optics · Molecular Communication and Nanonetworks · Micro and Nano Robotics
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (67)
Show source-provided references
1. Cancer statistics, 2024
2. Melanoma risk prediction based on a polygenic risk score and clinical risk factors10.1097/CMR.0000000000000896 ↗
3. Risk factors and innovations in risk assessment for Melanoma, basal cell carcinoma, and squamous cell carcinoma10.3390/cancers16051016 ↗
4. Metformin regulates the proliferation and motility of melanoma cells by modulating the LINC00094/miR-1270 axis10.1186/s12935-024-03545-5 ↗
5. Generation of 3D melanoma models using an assembloid-based approach10.1016/j.actbio.2024.02.023 ↗
6. Adoptive T(reg) therapy with metabolic intervention via perforated microneedles ameliorates psoriasis syndrome10.1126/sciadv.adg6007 ↗
7. Treating the treatment: chemotherapy-induced multi-organ toxicity
8. Transdermal delivery of Cu-doped polydopamine using microneedles for photothermal and chemodynamic synergistic therapy against skin melanoma10.1016/j.cej.2021.130790 ↗
9. A self-monitoring microneedle patch for light-controlled synergistic treatment of melanoma
10. Recent advances in nanotechnology for the treatment of melanoma10.3390/molecules26040785 ↗
11. Printable personalized drug delivery patch for the topical therapy of skin diseases10.1016/j.matt.2022.09.018 ↗
12. Human skin equivalents: impaired barrier function in relation to the lipid and protein properties of the stratum corneum10.1016/j.addr.2021.05.012 ↗
13. Metallic elements combine with herbal compounds upload in microneedles to promote wound healing: a review10.3389/fbioe.2023.1283771 ↗
14. Research progress of microneedles in the treatment of melanoma10.1016/j.jconrel.2022.06.021 ↗
15. Tellurium nanoparticles and Fucoidan-loaded dissolvable microneedles for combined photothermal therapy and anti-angiogenesis in melanoma treatment10.1016/j.ijbiomac.2024.139153 ↗
16. Microneedle-based nanodrugs for tumor immunotherapy10.1016/j.jconrel.2025.02.003 ↗
17. Wearable clinic: from microneedle-based sensors to next-generation healthcare platforms10.1002/smll.202207539 ↗
18. Metal-organic framework microneedles for precision transdermal drug delivery: design strategy and therapeutic potential
19. Fluorescent-based biodegradable microneedle sensor array for tether-free continuous glucose monitoring with smartphone application10.1126/sciadv.adh1765 ↗
20. Transdermal electroosmotic flow generated by a porous microneedle array patch10.1038/s41467-021-20948-4 ↗
21. Microorganism microneedle micro-engine depth drug delivery10.1038/s41467-024-53280-8 ↗
22. A bioactive injectable hydrogel regulates tumor metastasis and wound healing for Melanoma via NIR-light triggered hyperthermia
23. A dendritic cell-recruiting, antimicrobial blood clot hydrogel for melanoma recurrence prevention and infected wound management10.1016/j.biomaterials.2024.122776 ↗
24. Photosensitizer micelles together with IDO inhibitor enhance cancer photothermal therapy and immunotherapy
25. Transforming weakness into strength: photothermal-therapy-induced inflammation enhanced cytopharmaceutical chemotherapy as a combination anticancer treatment
26. Engineered carrier-free nanosystem-induced in situ therapeutic vaccines for potent cancer immunotherapy10.1021/acsami.4c09925 ↗
27. Tumor-targeted glutamine metabolism blocker synergizes with TiO(2)-Au janus nanoparticles for enhanced sono-metabolic antitumor therapy
28. pH/ATP cascade-responsive nano-courier with efficient tumor targeting and siRNA unloading for photothermal-immunotherapy10.1016/j.nantod.2021.101083 ↗
29. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence10.1016/j.actbio.2021.09.014 ↗
30. Mechanisms of immune activation and regulation: lessons from melanoma10.1038/s41568-022-00442-9 ↗
31. PhotoPyro-Induced cGAS-STING pathway activation enhanced anti-melanoma immunotherapy via a manganese-coordinated nanomedicine10.1002/adhm.202302811 ↗
32. DC-derived whole cell cytokine nano-regulator for remodelling extracellular matrix and synergizing tumor immunotherapy10.1039/D4MD00496E ↗
33. Tumor-specific delivery of clickable inhibitor for PD-L1 degradation and mitigating resistance of radioimmunotherapy10.1126/sciadv.adq3940 ↗
34. Engineering kinetics of TLR7/8 agonist release from bottlebrush prodrugs enables tumor-focused immune stimulation10.1126/sciadv.adg2239 ↗
35. Multifunctional biomimetic nanocarriers for dual-targeted immuno-gene therapy against hepatocellular carcinoma
36. Nanomedicine-mediated ubiquitination inhibition boosts antitumor immune response via activation of dendritic cells
37. Cancer vaccines in the clinic10.1002/btm2.10588 ↗
38. PAK1 inhibition increases TRIM21-induced PD-L1 degradation and enhances responses to anti-PD-1 therapy in pancreatic cancer10.1016/j.bbadis.2024.167236 ↗
39. First-line camrelizumab (a PD-1 inhibitor) plus apatinib (an VEGFR-2 inhibitor) and chemotherapy for advanced gastric cancer (SPACE): a phase 1 study10.1038/s41392-024-01773-9 ↗
40. Bio-orthogonal click chemistry strategy for PD-L1-targeted imaging and pyroptosis-mediated chemo-immunotherapy of triple-negative breast cancer10.1186/s12951-024-02727-7 ↗
41. Targeted delivery of anti-miRNA21 sensitizes PD-L1(high) tumor to immunotherapy by promoting immunogenic cell death10.7150/thno.97755 ↗
42. Clinical experience with CTLA-4 blockade for cancer immunotherapy: from the monospecific monoclonal antibody ipilimumab to probodies and bispecific molecules targeting the tumor microenvironment10.1016/j.phrs.2021.105997 ↗
43. XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer10.1136/jitc-2023-007785 ↗
44. Overcoming the cardiac toxicities of cancer therapy immune checkpoint inhibitors10.3389/fonc.2022.940127 ↗
45. Efficacy and safety of PD-1/PD-L1 and CTLA-4 immune checkpoint inhibitors in the treatment of advanced colorectal cancer: a systematic review and meta-analysis10.3389/fimmu.2024.1485303 ↗
46. Zebularine potentiates anti-tumor immunity by inducing tumor immunogenicity and improving antigen processing through cGAS-STING pathway10.1038/s42003-024-06271-w ↗
47. Current trends in gas-synergized phototherapy for improved antitumor theranostics10.1016/j.actbio.2023.12.012 ↗
48. Bandgap-engineered germanene nanosheets as an efficient photodynamic agent for cancer therapy
49. XPS and SEM studies of oxide reduction of germanium nanowires10.1016/j.jnoncrysol.2010.05.042 ↗
50. Size-tunable photothermal germanium nanocrystals10.1002/anie.201701321 ↗
51. Dirac signature in germanene on semiconducting substrate10.1002/advs.201800207 ↗
52. 2D monoelemental germanene quantum dots: synthesis as robust photothermal agents for photonic cancer nanomedicine10.1002/anie.201908377 ↗
53. Antimonene quantum dots: synthesis and application as near-infrared photothermal agents for effective cancer therapy10.1002/anie.201703657 ↗
54. PEGylated WS2 nanosheets as a multifunctional Theranostic agent for in vivo dual-modal CT/Photoacoustic imaging guided photothermal therapy10.1002/adma.201304497 ↗
55. Black phosphorus nanosheets as a neuroprotective nanomedicine for neurodegenerative disorder therapy10.1002/adma.201703458 ↗
56. Photothermal properties of MXenes and sterilization of MRSA by Nb2C/Gel with a low power NIR-II laser10.1039/D4NJ00245H ↗
57. Fe3O4 clusters with high photothermal performance for photothermal therapy of tumor10.1016/j.cej.2024.159045 ↗
58. Engineering thermally reduced graphene oxide for synchronously enhancing photocatalytic activity and photothermal effect10.1021/acsabm.4c00862 ↗
59. Selenide heterostructure nanosheets with efficient near-infrared photothermal conversion for therapy10.1021/acsomega.2c07964 ↗
60. Single-atom Pd nanozyme for ferroptosis-boosted mild-temperature photothermal therapy10.1002/anie.202101924 ↗
61. Iron-reduced graphene oxide core-shell micromotors designed for magnetic guidance and photothermal therapy under second near-infrared light10.3390/pharmaceutics16070856 ↗
62. Three dimensional printing and its applications focusing on microneedles for drug delivery10.3390/pharmaceutics15061597 ↗
63. State-of-the-art strategies to enhance the mechanical properties of microneedles10.1016/j.ijpharm.2024.124547 ↗
64. Built-In active microneedle patch with enhanced autonomous drug delivery10.1002/adma.201905740 ↗
65. Biologics-loaded photothermally dissolvable hyaluronic acid microneedle patch for psoriasis treatment10.1002/adfm.202205847 ↗
66. Coordination-driven enhancement of radiosensitization by black phosphorus via regulating tumor metabolism10.1021/acsnano.0c09454 ↗
67. L-Arginine self-delivery supramolecular nanodrug for NO gas therapy10.1016/j.actbio.2023.07.055 ↗